Author:
Franklin Wilbur A.,Shpall Elizabeth J.,Archer Philip,Johnston Charles S.,Garza-Williams Sara,Hami Lisa,Bitter Mitchell A.,Bast Robert C.,Jones Roy B.
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Peters WP, Shpall EJ, Jones RB et al.: High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 6: 1368–1375, 1988
2. Peters WP, Davis R, Shpall EJ et al.: Adjuvant chemotherapy involving high-dose combination cyclophosphamide, cisplatin, carmustine (CPA/CDDP/BCNU with bone marrow support for stage II/II breast cancer involving ten or more lymph nodes (CALGB 8782): A preliminary report. Proc Am Soc Clin Oncol 9: 22, 1990 (abstr)
3. Kennedy MJ, Beveridge RA, Rowley SD, Gordon GB, Abeloff MD, Davidson NE: High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer. J Natl Cancer Inst 83: 920–926, 1991
4. Vincent MD, Powles TJ, Coombes RC, McElwain TJ: Late intensification with high-dose melphalan and autologous bone marrow support in breast cancer patients responding to conventional chemotherapy. Cancer Chemother Pharmacol 21: 255–260, 1988
5. Dunphy FR, Spitzer G, Buzdar AU et al.: Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support. J Clin Oncol 8: 1207–1216, 1990
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献